Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis

Journal of the South African Veterinary Association

 
 
Field Value
 
Title Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
 
Creator Smit, Yolandi Marais, Hendrik J. Thompson, Peter N. Mahne, Arnold T. Goddard, Amelia
 
Subject veterinary; equine; lameness horse; osteoarthritis; platelet-rich plasma; intra-articular
Description Osteoarthritis is a common cause of lameness in horses, resulting in poor performance. Intra-articular platelet-rich plasma can deliver a collection of bioactive molecules, such as autologous growth factors and proteins involved in the quality of tissue repair. Horses (n=5) with osteoarthritis affecting antebrachiocarpal, middle carpal or metacarpophalangeal joints, and horses (n=5) without osteoarthritis of the corresponding joints (radiographically free of osteoarthritis), were used for the production of platelet-rich plasma which was subsequently injected into selected joints. Clinical and synovial fluid changes after intra-articular injection of platelet-rich plasma as well as synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentration changes were evaluated in these joints and compared between normal joints and joints with osteoarthritis. A gravity filtration system produced a moderately concentrated platelet-rich plasma, representing a 4.7-fold increase in baseline platelet concentration. The synovial effusion score was significantly different between the control joints and joints with osteoarthritis on Day 0 with a higher score in the group with osteoarthritis. Within the control group, the synovial effusion score was significantly higher on Days 1 and 2 compared to Day 0. For both groups, the synovial fluid nucleated cell count, predominantly intact neutrophils, was significantly increased on Days 1 and 2, with no significant difference between groups. The mean synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentrations were increased for both groups but significantly lowered in the group with osteoarthritis on Day 1 compared to normal joints. Concentrations for platelet-derived growth factor-BB remained unchanged on Day 5, compared to Day 1, with no significant difference between groups. In conclusion, intra-articular treatment with platelet-rich plasma resulted in increased synovial growth factor concentrations in joints but with lower concentrations in joints with osteoarthritis. A transient inflammatory reaction was seen both clinically as an increase in synovial effusion and cytologically in both normal joints and joints with osteoarthritis.
 
Publisher AOSIS
 
Contributor HWSETA
Date 2019-05-23
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format text/html application/epub+zip application/xml application/pdf
Identifier 10.4102/jsava.v90i0.1721
 
Source Journal of the South African Veterinary Association; Vol 90 (2019); 9 pages 2224-9435 1019-9128
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://jsava.co.za/index.php/jsava/article/view/1721/2381 https://jsava.co.za/index.php/jsava/article/view/1721/2380 https://jsava.co.za/index.php/jsava/article/view/1721/2382 https://jsava.co.za/index.php/jsava/article/view/1721/2379
 
Coverage South Africa — synovial; blood
Rights Copyright (c) 2019 Yolandi Smit, Hendrik J. Marais, Peter N. Thompson, Arnold T. Mahne, Amelia Goddard https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT